In a move poised to reshape the global metabolic API landscape, leading Viking pharmaceutical company Valhalla Labs has announced a groundbreaking strategic alliance with a prominent American Tirzepatide firm. This partnership will see both entities collaborate on enhancing the supply chain for metabolic APIs, ensuring uninterrupted access to vital